Keywords: sanofi-synthelabo, aiming, minimum, earnings, growth, full-year, says
Sanofi-Synthelabo aiming for minimum 20% earnings growth for full-year 2000
Article | 30 May 2000
Sanofi-Synthelabo says it expects full-year 2000 earnings to grow"substantially superior" to 20%, helped by currency fluctuations. Chief executive Jean-Francois Dehecq told ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
